Comparison of cefepime and meropenem use in treatment of neutropenic fever;Nötropeni̇k ateşli̇ çocuklarin tedavi̇si̇nde karşilaştirilmasi

Gulhane Medical Journal

Volumn 46, Issue 2, 2004, Pages 102-105

  Atay, Abdullah Avni ^a   Kismet, Erol ^a   Karaoǧlu, Abdulbaki ^a   Kürekç, Ahmet Emin ^a   Baysallar, Mehmet ^a   Köseoǧlu, Vedat ^a   Özcan, Okan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cefepime; Children; Malignancy; Meropenem; Neutropenic Fever

Indexed keywords

CEFEPIME; MEROPENEM;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG COST; FEBRILE NEUTROPENIA; FEMALE; GERM CELL TUMOR; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; MALE; NEUROBLASTOMA; NEUROECTODERM TUMOR; SOLID TUMOR;

EID: 3242677280     PISSN: 13020471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tamura, K., Matsuoka, H., Tsukada, J., Masuda, M., Ikeda, S., Matsuishi, E., Kawano, F., Izumi, Y., Uike, N., Utsunomiya, A., Saburi, Y., Shibuya, T., Imamura, Y., Hanada, S., Okamura, S., Gondoh, H.; Kyushu: Hematology Organization for Treatment (K-HOT) Study Group. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study. Am. J Hematol 2002; 71: 248-255.
2. Borbolla, J.R., Lopez-Hernandez, M.A., Gonzalez-Avante, M., DeDiego, J., Trueba, E.: Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients. Chemotherapy 2001; 47: 381-384.
3. Kebudi, R., Gorgun, O., Ayan, I.: Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors. Med Pediatr Oncol 2001; 36: 434-441.
4. Feld, R., DePauw, B., Berman, S., Keating, A., Ho, W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial. J Clin Oncol 2000; 18: 3690-3698.
5. Tanindi, Ş., Alpay, F., Köseoǧlu, V., Kürekçi, E., Özcan, O. Kanserli çocuklarin granulositopenik ateşli ataklarinin ampirik tedavisinde ceftazidime ve sulbaktam/cefaperazone monoterapisinin karşilaştirilmasi. GATA Bülteni 1994; 36: 1-6.
6. The meropenem Study Group of Leuven, London and Nijmegen. Equivelant efficacies of meropenem and ceftazidime as empirical monotherapy of febril neutropenic patients. J Antimicrob Chemother 1995; 36: 185-200.
7. Petrilli, A.S., Dantas, L.S., Campos, M.C., Tanaka, C., Ginani, V.C., Seber, A. Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Pediatr Oncol. 2000; 34: 87-91.
8. Pizzo, P.A.: Management of fever in patients with cancer and treatment-induced neutropenia. New England J Med 1993; 328: 1323-1332.
9. Rubin, R.H.: Empirical antibacterial therapy in granulocytopenia induced by cancer chemotherapy. Ann Intern Med 1988; 108: 134-136.
10. Schimph, S.C.: Overview of empirical antibiotic therapy for the febrile neutropenic patient. Rev Infect Dis 1985; 7: 734-740.
11. Pennington, J.E.: Fever, neutropenia and malignancy: A clinical syndrome in evolution. Cancer 1977; 39: 1345-1349.
12. The International Antimicrobial Therapy Project Group of the EORTC. Combination of amikacin and carbenicillin with or without cefazolin as empiric treatment of febrile neutropenic patients. J Clin Oncol 1983; 1: 597-603.
13. Kaptan, K., Beyan, C., Özyurt, M., Ural, A.U., Baş ustaoǧlu, A., Avcu, F., Gün, H., Yalçin, A.: Febril notröpenik olgularda seftazidim-amikasin kombinasyonu. GATA Bülteni 1998; 40: 305-309.
14. Engervall, P., Kalin, M., Dombusch, K., Bjorkholm, M.: Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia:a randomized, singlecenter phase II trial. J Chemother 1999; 11: 278-286.
15. Hughes, W.T., Armstrong, D., Bodey, G.P., Feld, R., Mandell, G.L., Myers, J.D., Pizzo, P.A., Schimpfy S.C.: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381-396.
16. Agaoglu, L., Devecioglu, O., Anak, S., Karakaş, Z., Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey. J Chemother 2001; 13: 281-287.
17. Ariffin, H., Arasu, A., Mahfuzah, M., Ariffin, W.A., Chan, L.L., Lin, H.P. Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer. J Paediatr Child Health 2001; 37: 38-43.
18. Freifeld, A.G., Hathorn, J.W., Pizzo, P.A.: Infectious complications in the paediatric cancer patient. In: Principles and Practice of Paediatric Oncology. 2nd ed., Lippincott, Philadelphia 1993: 987-1020.
19. Klastersky, J.: Therapy of infections in cancer patients. In: Handbook of supportive care in cancers (Klastersky J, Schimpff SC, Senn HJ ed), Marcel Dekker Inc, New York, 1995: 1-44.